Anxiety, a prevalent mental disorder, is treated with drugs that exhibit adverse effects. The goal of GABAPAID is to develop and validate in vivo an innovative biotherapeutic solution - a functional food enriched with microbial GABA and GABA-generating probiotics aimed at modulating neurotransmitters and the gut-brain axis for anxiety relief and mental health promotion.